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AbstrACt
Introduction In April 2019, 14 children were diagnosed 
with HIV infection by a private healthcare provider in Larkana 
district, Sindh province, Pakistan. Over the next 3 months, 
930 individuals were diagnosed with HIV, >80% below 16 
years, the largest ever outbreak of HIV in children in Pakistan. 
In this protocol paper, we describe research methods for 
assessing likely modes of HIV transmission in this outbreak 
and investigate spatial and molecular epidemiology.
Methods and analysis A matched case–control study 
will be conducted with 406 cases recruited. Cases will be 
children aged below 16 years registered for care at the 
HIV treatment centre at Shaikh Zayed Children Hospital in 
Larkana City. Controls will be children who are HIV- uninfected 
(confirmed by a rapid HIV test) matched 1:1 by age (within 
1 year), sex and neighbourhood. Following written informed 
consent from the guardian, a structured questionnaire 
will be administered to collect data on sociodemographic 
indices and exposure to risk factors for parenteral, vertical 
and sexual (only among those aged above 10 years) HIV 
transmission. A blood sample will be collected for hepatitis B 
and C serology (cases and controls) and HIV lineage studies 
(cases only). Mothers of participants will be tested for HIV to 
investigate the possibility of mother- to- child transmission. 
Conditional logistic regression will be used to investigate the 
association of a priori defined risk factors with HIV infection. 
Phylogenetic analyses will be conducted. Global positioning 
system coordinates of participants’ addresses will be 
collected to investigate concordance between the genetic 
and spatial epidemiology.
Ethics and dissemination Ethical approval was granted 
by the Ethics Review Committee of the Aga Khan University, 
Karachi. Study results will be shared with Sindh and 
National AIDS Control Programs, relevant governmental 
and non- governmental organisations, presented at national 
and international research conferences and published in 
international peer- reviewed scientific journals.
IntroduCtIon
The HIV epidemic in Pakistan has been 
predominantly concentrated in adults 
among groups with high- risk behaviour such 
as people who inject drugs (PWID), men 
who have sex with men, transgenders and 
sex workers.1 In 2018, an estimated 160 000 
people were living with HIV in Pakistan, with 
2.2% being children aged below 15 years.2
In April 2019, a private practitioner in 
taluka (division) Ratodero, District Larkana 
in the Sindh province of Pakistan diagnosed 
strengths and limitations of this study
 ► Our study will provide information on the likely 
routes of infection and drivers of the HIV outbreak 
among children in Pakistan, which is critical to in-
form appropriate interventions and targeted strate-
gies for HIV prevention.
 ► The study incorporates molecular epidemiology in-
cluding the prevalence of different HIV subtypes and 
circulating recombinant forms, phylogenetic cluster-
ing, genetic recency and drug resistance, which will 
provide an in- depth understanding of the dynamics 
of the HIV epidemic in the country.
 ► This study also includes spatial data which will al-
low us to explore concordance between spatial and 
genetic clustering observed in this HIV outbreak. 
Additional spatial data on all local government and 
private sector health facilities including laboratories, 
blood banks, formal and informal healthcare provid-
ers will be collected which will allow investigation 
of potential relationships between case location and 
the acquisition of infection.
 ► The study is prone to selection bias and the controls 
may not be representative of the population and ex-
posures are ascertained by self- report and therefore 
subject to recall bias.
 ► Widespread reporting in the media about the likeli-
hood of the outbreak having occurred as a result of 
contaminated needles may result in over- reporting 
of receipt of injections.
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Table 1 HIV prevalence and interactions between key population groups in Larkana district, Pakistan in surveillance survey 
rounds
Round II14
(2006)
Round III15
(2008)
UNGASS Report17
(2010)
Round IV16
(2013)
Round V1
(2016–17)
HIV prevalence in PWID 14% 28.5% 28% 18.6% 16.2%
HIV prevalence in TG- SW – 27.6% 27% 14.9% 18.2%
  Clients per month, n 119 106
  % Consistent condom use 37.2% 7.9%
HIV prevalence in FSW 0% – 0.61% 1.9% 4.1%
  % Unmarried 11.3%
  % Married children 82.9%
HIV prevalence in MSM – – – – 4.9%
HIV prevalence in MSW 2.5% 0.5% 0.5% 3.1% 5%
% MSM injecting drugs in past 12 months – 18% – – 10.6%
% TG injecting drugs in past 12 months – 23% – – 0.7%
% MSM having sex with PWID in past 12 months – 6% – – 11.2%
% TG- SW having sex with PWID in past 12 months 1.8% 14.1% – – 1.1%
% FSW having sex with PWID in past 12 months 0.3% – – – 0.5%
% PWID paid FSW in past 6 months 3.3% 9% – – 52.5%
% PWID paid MSW/TG in past 6 months 9% 13% – – 68.8%
FSW, female sex worker; IBBS, Integrated Biological & Behavioral Surveillance; MSM, men who have sex with men; MSW, male sex worker; PWID, 
people who inject drugs; SW, sex worker; TG, transgender; UNGASS, United Nations General Assembly Special Session on HIV/AIDS.
14 children with HIV, based on clinical suspicion. As part 
of the response, the federal and provincial established 
an HIV screening camp at Tehsil Hospital Ratodero, a 
public- sector hospital, with voluntary counselling and 
testing offered to any individual attending the camp 
regardless of age. Between April and July 2019, 930 indi-
viduals tested HIV positive of whom 763 were children 
aged below 16 years.3 This constituted a 54% increase 
in the cumulative number of paediatric HIV diagnoses 
over the past 13 years. By 4 December 2019, 952 children 
with HIV had been identified (personal communica-
tion: Sindh AIDS Control Program (SACP)). Although 
there have been several HIV outbreaks over the past two 
decades, none has ever been so large nor significantly 
affected children.4–8
The scale of the outbreak and the age of the individuals 
affected by the outbreak raise important questions about 
the epidemiology of HIV infection and the mode of trans-
mission of HIV infection. The most widely accepted cause 
of this outbreak is thought to be the reuse of needles by 
health practitioners and transfusion of contaminated 
blood products.9 10 Nosocomial outbreaks of HIV infec-
tion have previously been reported in Pakistan and other 
countries, but have mostly been related to a specific 
health facility and have not been at this scale.5 11 12 In a 
report of the outbreak, we reported that the proportion 
of infants with an HIV- positive mother was significantly 
higher than that among older children, implying that 
vertical transmission may have contributed to transmis-
sion.3 Although there has been an unexpectedly high 
number of paediatric HIV diagnoses, it is by no means 
certain that the acquisition of infection by children was 
recent or from one source. It is possible that transmis-
sion of HIV may have been ongoing in the community for 
some time and the increased detection may be a conse-
quence of the vigorous screening efforts implemented by 
the provincial AIDS Control Program in response to the 
initial diagnoses. Thus, this ‘outbreak’ may be an indi-
cator of the bridging of the concentrated HIV epidemic 
in key populations into the general population.13
In successive rounds of HIV surveillance surveys 
among key populations in Pakistan, the HIV prevalence 
among PWID has remained persistently extremely high 
in Larkana, and there has been an upward trend in HIV 
prevalence among both male and female sex workers 
(table 1).1 14–17 Importantly, there is evidence for inter-
actions between different groups that could lead to HIV 
epidemic bridging (table 1).18 In addition, low condom 
usage and large population densities of key population 
groups in Larkana provide considerable potential for 
the expansion of the HIV epidemic into the general 
population.4
This protocol paper describes a study to investigate the 
epidemiology, including the spatial and molecular epide-
miology of the outbreak in Sindh.
MEthods
study aims and design
The overall aim of the study is to investigate the outbreak 
of HIV infection among children in Sindh province, 
 o
n
 April 2, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036723 on 25 March 2020. Downloaded from 
3Siddiqui AR, et al. BMJ Open 2020;10:e036723. doi:10.1136/bmjopen-2019-036723
Open access
Figure 1 Map of the study sites.
Pakistan, to inform HIV control strategies. Specific objec-
tives are to:
1. Investigate the likely risk factors for and routes of HIV 
infection in children aged below 16 years.
2. Explore the molecular epidemiology, specifically the 
range of HIV subtypes recombinant forms, phyloge-
netic clustering, genetic recency of infections and 
prevalence of drug resistance mutations in children 
with HIV identified in the outbreak.
3. Examine spatial clustering of cases using several tech-
niques, including geographic profiling, and assess the 
concordance between spatial and genetic clusters.
A matched case–control study will be conducted among 
children aged below 16 years. Cases will be children 
with HIV and controls will be HIV- uninfected children 
matched 1:1 to cases by age, sex and neighbourhood. 
Data will be collected on likely exposures using a struc-
tured questionnaire and global positioning system (GPS) 
coordinates of the address of cases and controls will be 
recorded. A blood sample will be collected for hepatitis B 
and C serology and HIV viral lineage studies (cases only) 
and mothers of all participants will be tested for HIV.
study setting
There has been an adult HIV treatment centre at the 
Civil Hospital in Larkana city since 2007. Given the large 
numbers of paediatric HIV diagnoses, the SACP estab-
lished a paediatric HIV treatment clinic at the neigh-
bouring Shaikh Zayed Children’s Hospital in April 2019, 
where >90% of children diagnosed with HIV (potential 
cases) through the screening camps have been registered. 
Following a reactive HIV test (Alere HIV Combo) at the 
screening camp, confirmatory testing is carried out using 
two different rapid tests (SD Bioline and Unigold).
The majority of children with HIV identified in the 
outbreak are from Larkana district but any children living 
in the adjoining districts, Shikarpur and Qambar Shah-
dadkot, will also be eligible to participate in the study 
(figure 1). These three districts are situated in Sindh, the 
second- most populous province of Pakistan. Larkana is 
divided into four talukas (Larkana city, Ratodero, Dokri 
and Bakrani) and has a population of 1 524 391 (2015), 
comprising 13.5% of the province’s population, with 40% 
aged under 15 years and 16.4% aged below 5 years.19 The 
district has among the worst health indicators in the prov-
ince: the infant mortality rate is 109 per 1000 live births, 
the under-5 mortality rate 142 per 1000 live births, a third 
of births have low birth weight (<2.5 kg) and 20% of under 
5 years of age have severe acute malnutrition. A quarter of 
households are in the poorest wealth quintiles.20
Participant recruitment
A case will be defined as a child aged below 16 years regis-
tered for HIV care at the paediatric HIV treatment centre 
in Larkana city, regardless of whether she/he is taking 
antiretroviral therapy (ART). A control matched for sex, 
age (±1 year) and neighbourhood will be defined as an 
individual who tests HIV negative. Exclusion criteria will 
be the lack of consent from a guardian or assent from the 
child to participate in the study.
A list of children registered at the Paediatric Treatment 
Center at Shaikh Zayed Children’s Hospital (potential 
cases) will be obtained after the permission from the 
SACP. The list will contain the name, age and contact 
details of children with HIV registered for care. The study 
team will sign an agreement to keep this list confidential 
and within office premises. The research team will contact 
the caregiver of each child by phone from the office and 
provide information about the study and invite them to 
participate. If they agree, a home visit will be arranged. 
If an individual is not contactable, then the team will 
contact the next individual on the list. The list will be kept 
under lock and key at the study office. For each case, a 
control will be enrolled from the same neighbourhood 
(‘muhallah’). Once a case is recruited, the study team 
will approach the neighbouring dwelling and enquire if 
there is a child with matching age and sex residing in the 
dwelling. If there is, information about the study will be 
provided and the child invited to participate as a control. 
If there is not, then the study team will approach the 
next dwelling along on the same street (covering both 
sides of the street) until an appropriate eligible control 
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Figure 2 Study flow. GPS,global positioning system; SZCH, Shaikh Zayed Children’s Hospital,Larkana City.
is identified. If there is no control identified in the same 
street, then the research team will move to the adjacent 
street. All eligible controls will be screened for HIV prior 
to recruitment (see the ‘Study procedures’ section).
study procedures
Study staff will be trained on consent procedures, data 
collection including GPS data, HIV counselling and 
testing and collection of blood specimens and all study 
tools will be piloted.
After consent and assent are obtained, eligible controls 
will undergo rapid HIV testing using a fourth- generation 
rapid blood- based test (Alere HIV Combo) and recruited 
into the study if they test HIV negative. For those aged 
below 18 months, molecular HIV testing will be carried 
out if the antibody test is positive and the mother’s test 
is HIV positive. In the event that an eligible control’s 
HIV test is reactive, an alternative eligible control will 
be identified. A structured questionnaire will be admin-
istered to the participants’ parents/caregivers or the 
participants themselves if they are aged above 10 years. 
Sociodemographic data including age, sex, religion, 
ethnicity, schooling, marital status and household socio-
economic status of the participant, and the vital status, 
HIV status and HIV testing history of the participant’s 
biological parents and natural siblings (defined as those 
with the same mother) will be collected. For cases only, 
information about the HIV testing and treatment history 
including date of HIV diagnosis and ART initiation (if 
applicable) will be recorded.
The questionnaire will contain questions about expo-
sures for HIV infection including frequency of contact 
with different types of healthcare services (private hospi-
tals or clinics, government hospitals, basic health units 
or rural health centre) and receipt of injections, intra-
venous fluid (‘drips’), surgery and blood transfusions. If 
participants have received a blood transfusion, then the 
frequency and reason for transfusion, the location of the 
transfusion and the source of the blood product (blood 
bank, donation by a family member or friend) will be 
recorded. Where possible, responses will be cross- checked 
against participant- held medical records. Cultural prac-
tices such as circumcision (male individuals only), head 
shaving, tattooing, nose or ear piercing and engaging in 
‘zanjeer zani’ (self- flagellation using knives for mourning 
the martyrdom of Prophet Muhammad’s grandson in 
the first month of the Islamic calendar) will be recorded. 
Participants who are aged above 10 years will also be asked 
about the history of consensual or non- consensual sexual 
intercourse and intravenous drug use including needle 
sharing. Questions on the existence of brothels, drug 
dens and hospital waste dumps in the neighbourhood will 
be asked. The questionnaires are available on request.
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Table 2 Sample size estimates
Probability of 
exposure among 
controls
Correlation of 
exposure
Power, 
%
Minimum OR 
detected
0.1 0.2 80 1.94
0.1 0.2 90 2.12
0.1 0.4 80 2.18
0.1 0.4 90 2.43
0.5 0.2 80 1.56
0.5 0.2 90 1.67
0.5 0.4 80 1.67
0.5 0/4 90 1.81
0.8 0.2 80 1.81
0.8 0.2 90 2.00
0.8 0.4 80 1.98
0.8 0.4 90 2.21
0.95 0.2 80 3.56
0.95 0.2 90 4.45
0.95 0.4 80 4.23
0.95 0.4 90 5.39
A blood sample will be collected from participants for 
hepatitis B and C serological testing and viral lineage 
studies (for cases only). Mothers of all participants will 
undergo HIV testing using the same rapid HIV test used 
to test eligible controls. Pretest and post- test counselling 
will be provided before any HIV testing is performed in 
the study. Results will be given on the same day. Anyone 
with a reactive HIV test will be referred to the paediatric 
or adult HIV clinic in Larkana for confirmatory testing 
and linkage to care. The study flow is summarised in 
figure 2.
specimen collection and transportation
Blood will be collected from participants in EDTA and 
gel top tubes (total volume 3–5 mL) labelled with the 
study ID number and packed in a Biohazard Zip- lock Bag. 
Blood samples will be maintained in an upright position 
at 2°C–4°C with frozen ice packs and transported within 
6–8 hours to the Aga Khan University (AKU) Infectious 
Disease Research Laboratory (IDRL) in Matiari (an AKU 
satellite research laboratory in Sindh) where the sample 
condition (temperature and evidence of leakage) will be 
checked and the sample details will be confirmed with 
those on the accompanying laboratory form. Samples 
will subsequently be dispatched daily to AKU in Karachi. 
Hepatitis B and C serology and viral lineage studies will 
be performed at the IDRL and the Department of Basic 
Biological Sciences at AKU respectively.
Viral lineage and drug resistance studies
Viral nucleic acid will be extracted from the blood sample 
of cases using commercially available kits (Qiagen) 
following the manufacturer’s instructions, and the 
Gag- Pol region of the HIV genome will be amplified by 
PCR using previously optimised protocols. The ampli-
cons will be purified and undergo Sanger sequencing 
(Macrogen, Korea). The sequences will be edited, the 
HIV subtype determined and the phylogenetic relation-
ship between different HIV subtypes will be analysed.
Geospatial data
GPS coordinates of the households of participants will 
be obtained and recorded using smartphones. Location 
data of all known local government and private health 
facilities including hospitals, primary healthcare clinics, 
local laboratories, local blood banks, informal healthcare 
providers/pharmacists, local barbers and body piercing 
outlets in the town and surrounding area will be collected
data management
Data will be collected on paper forms and each completed 
data form will be checked by the field supervisor for 
missing or incorrect data prior to data entry. Data will 
be double entered into a password- protected database 
(Visual FoxPro V.9.0). Data cleaning will include range 
checks and checks for missing values and the final cleaned 
dataset will be deidentified for analysis. Where possible, 
the transmission of data through email will be avoided 
and a secure file transfer server will be used to transmit 
the data. Data files will be deidentified with unique study 
identifiers (study IDs) incorporated. All electronic files 
will be password protected. Data will be backed up on 
a server (with weekly offsite backup) and paper forms 
will be stored in locked cabinets for 3 years after study 
completion. Passwords will be assigned to all machines 
storing data and only accessible to authorised personnel. 
GPS data will be collected using mobile phone devices 
that will be stored securely during the study. All GPS data 
will be deleted from devices after entry on to data forms.
sample size estimates
Assuming a probability of exposure to injections among 
controls of 0.8 and a correlation coefficient for exposure 
between matched case and control of 0.4, a sample size 
of 406 HIV cases and 406 controls matched on age, sex 
and area of residence will provide at least 80% power to 
detect an OR of at least 1.98 at a two- sided significance 
level of 0.05. Table 2 shows that there will be at least 80% 
to detect an OR of ≥2.0 for the probability of exposures 
ranging from 0.1 to 0.85 and a correlation coefficient for 
exposure between matched HIV case and control subjects 
of 0.20.
data analyses
Case–control study
Statistical analysis will be done using STATA (V.14 or 
later). Continuous variables will be presented as means 
(SD) if normally distributed or median (IQR) if skewed. 
Categorical data will be presented as proportions. Our 
dataset will include cases individually pair- matched to 
controls of the same age, sex and neighbourhood (usually 
living on the same street). The bivariate analysis will be 
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used to determine crude ORs and 95% CIs for the asso-
ciation of HIV with key exposures related to parenteral 
(eg, receipt of injections, history of injection drug use, 
history of blood transfusion, history of surgery, hepatitis 
B or C antibody positivity and so on), vertical (maternal 
and/or sibling HIV status) or sexual transmission. Multi-
variable conditional logistic regression will be conducted 
to control for confounding and adjusted ORs for expo-
sures in cases compared with controls with 95% CIs will 
be computed. Conditional logistic regression is required 
because each case will be individually pair- matched 
to a control of the same age, sex and neighbourhood. 
Adjusting for age and gender will still be required as the 
matching itself can introduce a bias.21
Genomic analyses
Cluster analysis will be performed to identify statisti-
cally significant nodes on the phylogenetic tree and the 
supported clusters. The node age, node substitution and 
branch length of each sequence will be used to iden-
tify features such as the similarity between sequences 
or clusters, ancestral sequences, monophyletic clusters, 
founder effect and recombination. A Bayesian frame-
work will be used to determine the effective population 
size (correlated to the effective number of HIV transmis-
sion) and the time of the most recent common ancestor 
in Larkana taxa in relation to recognised HIV sequences 
from Pakistan. The Bayesian substitution tree will iden-
tify the rate of substitution for each cluster, which will be 
combined with pair- wise genetic distances to calculate 
the genetic recency of infection with the assumption that 
substations/genetic distance tends to increase with age or 
duration of infection. A Bayesian birth–death model will 
estimate the reproductive number for significant taxa to 
estimate the rate of the epidemic/outbreak growth.
The amino acid sequences of the HIV Pol gene (which 
codes for reverse transcriptase, HIV-1 protease and inte-
grase) will be aligned with the reference sequences to 
identify Pol mutations from both the groups. The asso-
ciation of Pol mutations with resistance to ART drugs 
will be determined using the Stanford Drug Resistance 
Database and counter- confirmed using the International 
AIDS Society report on drug resistance. The proportion 
of ART- naïve and ART- experienced cases with drug resis-
tance mutations will provide an understanding of the 
probability of transmitted drug resistance and suboptimal 
treatment adherence.
Geospatial analyses
Geographical profiling (GP), is a novel geospatial tool 
originally developed in criminology to prioritise large lists 
of suspects in cases of serial crime, using spatial locations 
of linked crimes to identify areas likely to be associated 
with the criminal. GP has the potential for use in the field 
of pathogen transmission research, as its aim is to identify 
source locations, rather than simply identifying spatial 
clustering of infection.
GP will be used to identify areas that are potential 
sources of nosocomial transmission using the location 
of cases whose mothers are HIV negative. The spatial 
relationship between locations of local government and 
private health facilities, local laboratories, local blood 
banks, informal healthcare providers, local barbers and 
body piercing outlets and so on and any GP- identified 
hotspots will be examined. GP will be carried out using 
Rgeoprofile (https:// github. com/ bobverity/ Rgeoprofile).
Traditional geospatial methods including non- 
parametric distance- based mapping approach,22 
kernel- density estimation23 and SaTScan24 will also be 
implemented to identify spatial clusters. The concordance 
between genetic and spatial clusters will be measured 
using permutation testing to address the hypothesis that 
there will be a statistically significant association between 
spatial groups identified by GP and genetic groups identi-
fied in the genomic cluster analyses detailed above.
Patient and public involvement
Patients or the public will not be involved in the design or 
conduct of the study. Results will be disseminated to the 
community.
study status
Ethical approval was obtained in July 2019. Recruitment 
began in July 2019 and epidemiological, phylogenetic 
and geospatial analysis protocols are being finalised.
dIsCussIon
Pakistan is one of only four countries in Asia where the 
incidence of HIV has continued to increase in the past 
decade. The number of new HIV infections increased 
from 14 000 in 2010 to 22 000 in 2018, with a 369% rise 
in HIV- related deaths over the same period.2 Although 
the HIV epidemic is mostly limited to key populations, 
outbreaks in the general population have occurred in 
previous years.4 8 The outbreak in Larkana, Sindh in 2019 
is the largest reported to date and the first time that chil-
dren have been predominantly affected.3 Although there 
has undoubtedly been a vigorous effort by the provin-
cial and federal government and other stakeholders to 
implement an appropriate response to the outbreak, 
understanding the drivers and the evolution of the HIV 
outbreak is critical to inform coherent middle- term and 
long- term strategies to control the HIV epidemic in 
Pakistan.
It has been widely assumed that the HIV outbreak is due 
to parenteral transmission through the reuse of needles 
in healthcare settings, although vertical transmission may 
also play a role.3 9 10 This study is important to identify 
the primary mode of HIV transmission in this outbreak to 
tailor context- specific interventions. There is also a need 
to establish whether the HIV outbreak has occurred as a 
result of a bridging of the HIV epidemic from high- risk 
groups into the general population (primarily children) 
through the nosocomial transmission.18
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Potential challenges include difficulties in tracing 
potential cases and in identifying eligible controls and 
low participation rates. A limitation of the study is that 
exposures to possible risks for HIV infection will be 
ascertained by self- report and therefore there is a risk of 
recall bias. Another limitation is that we have restricted 
length of recall of exposures to a period of 6 months for 
common exposures (use of injections) and 12 months 
for less common exposures (such as surgery) despite 
the possibility that children may have been infected 
earlier. Participants may not accurately recall exposures 
beyond a certain length of time and increasing length 
of recall of exposures can increase the risk of recall bias. 
Where possible, responses will be cross- checked against 
participant- held records. It is also possible that in chil-
dren, particularly older children, a particular exposure 
may have occurred after the acquisition of HIV infection. 
There has been widespread reporting of the likelihood 
of the outbreak occurring as a result of the widespread 
use of contaminated needles by healthcare providers. In 
particular, a doctor practising in Ratodero who treated 
many of the children who were subsequently diagnosed 
with HIV infection was implicated in spreading the infec-
tion, a story that received much media coverage in Paki-
stan.25 This may affect the accuracy of reporting of contact 
with healthcare providers by participants. Another limita-
tion is that the study is prone to selection bias. The study 
design has been chosen to improve efficiency and to 
enable control in the analysis of unquantifiable factors 
such as neighbourhood characteristics that might influ-
ence the risk of HIV infection (eg, access to healthcare 
providers).21 26 However, the controls may not be repre-
sentative of the level of exposure in the population.
The study will include geospatial and genomic analyses 
and will investigate the concordance between the genetic 
and spatial epidemiology to provide an in- depth under-
standing of the outbreak.
Ethics and dissemination
Ethical approval was sought and granted by Ethical 
Review Committee of the AKU, Karachi. Written 
informed consent in the local language will be obtained 
from parents or guardians of all participants and verbal 
assent from children aged 7 to 15 years. Data forms will 
contain no identifying information other than age, sex 
and Geographic Information System (GIS) coordinates. 
Laboratory forms will contain no identifying information, 
specimens will be identified by a study number only and 
test results will not be linked to any individual by name. 
All survey staff will sign a confidentiality agreement to 
ensure that they do not release participant identities and 
test or study results to individuals who are not part of the 
study team.
Study progress and findings will first be reported to the 
SACP and the National AIDS Control Program (NACP). 
Subsequently, results will be disseminated to health 
institutions and other relevant governmental and non- 
governmental organisations (NGOS) and community 
groups, for example, People’s Primary Healthcare Initia-
tive (PPHI), Integrated Health Services (IHS), Sindh 
Healthcare Commission (SHCC), Sindh Blood Trans-
fusion Authority (SBTA), Nai Zindagi Trust (an NGO 
working with PWIDs) and PRIH (an NGO working with 
sex workers). The study team is already engaged with rele-
vant stakeholders addressing this outbreak (SACP, NACP, 
WHO, UNICEF) and will participate in policy and advo-
cacy meetings to facilitate the development and imple-
mentation of strategies to strengthen HIV prevention and 
care in the country. Results will be presented at national 
and international research meetings and conferences 
and also prepared for publication in international peer- 
reviewed scientific journals. Study findings will be dissem-
inated to the study communities.
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